Post Profile

Samsung Affiliate Seeks European Approval for Herceptin Copy

Samsung Group’s biologic drug-development affiliate submitted a near-replica of blockbuster breast cancer drug Herceptin for regulatory approval in Europe.
read more


Related Posts

Breast Density Matters in Detection of Breast Cancer

Health : Newswise Medical News

Almost 8% of women have extremely high breast density, which can make it harder for health professionals to detect breast cancer on a screening mammogram. These women are also more likely to develop breast cancer in the future.

Roche To Submit Breast Cancer Drug Pertuzumab In USA And Europe Later This Year

Health : Medical News Today

Roche Holding announced it will submit its breast cancer drug Pertuzumab towards the end of 2011 for approval in the USA and Europe after Genentech (a Roche company) said its Phase III clinical evaluation of the Pertuzumab and trast...

FDA Approves New Test To Help Determine If Breast Cancer Patients Are Candidates For Herceptin Treatment

Health : Medical News Today

The U.S. Food and Drug Administration approved a new genetic test that will help health care professionals determine if women with breast cancer are HER2-positive and, therefore, candidates for Herceptin (trastuzumab), a commonly us...

Blocking IL-6 Improved Response To Breast Cancer Drug Herceptin

Health : Medical News Today

Breast cancer treatments such as Herceptin that target a marker called HER2 have dramatically improved outcomes for women with this type of cancer. But nearly half of these cancers are resistant to Herceptin from the start and almos...

Samsung Bioepis seeks Europe approval for its Herceptin copy

Health : Reuters: Health

SEOUL (Reuters) - Biosimilars maker Samsung Bioepis, part of South Korea's top conglomerate Samsung Group [SAGR.UL], said on Tuesday it is seeking regulatory approval in Europe to sell its copy of Roche's breast cancer drug Hercepti...


Copyright © 2016 Regator, LLC